These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8107487)

  • 1. Peripheral blood hairy cell leukemia cells express only low affinity IL-2 receptors.
    Bulger K; Murphy J; Janckila A; Nichols J; McCaffrey R
    Leuk Res; 1994 Feb; 18(2):101-4. PubMed ID: 8107487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHA induces IL-2 receptors on B-CLL cells and is a potential biological response modifier for the LIL-2-diphtheria toxin, DAB486IL-2.
    Bulger K; Padua F; Duff R; Pihan G; Nichols J; Murphy J; McCaffrey R
    Leuk Res; 1994 Feb; 18(2):119-22. PubMed ID: 8107488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein.
    Bacha P; Williams DP; Waters C; Williams JM; Murphy JR; Strom TB
    J Exp Med; 1988 Feb; 167(2):612-22. PubMed ID: 3126255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAB486IL-2 (IL-2 toxin) selectively inactivates high-affinity IL-2 receptor-bearing human peripheral blood mononuclear cells.
    Waters CA; Snider CE; Itoh K; Poisson L; Strom TB; Murphy JR; Nichols JC
    Ann N Y Acad Sci; 1991 Dec; 636():403-5. PubMed ID: 1793228
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells.
    Waters CA; Schimke PA; Snider CE; Itoh K; Smith KA; Nichols JC; Strom TB; Murphy JR
    Eur J Immunol; 1990 Apr; 20(4):785-91. PubMed ID: 2140788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor.
    LeMaistre CF; Meneghetti C; Rosenblum M; Reuben J; Parker K; Shaw J; Deisseroth A; Woodworth T; Parkinson DR
    Blood; 1992 May; 79(10):2547-54. PubMed ID: 1586707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells.
    Kiyokawa T; Williams DP; Snider CE; Strom TB; Murphy JR
    Protein Eng; 1991 Apr; 4(4):463-8. PubMed ID: 1881872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia.
    Kiyokawa T; Shirono K; Hattori T; Nishimura H; Yamaguchi K; Nichols JC; Strom TB; Murphy JR; Takatsuki K
    Cancer Res; 1989 Jul; 49(14):4042-6. PubMed ID: 2786749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human antigen-specific memory B cell response in vitro by a diphtheria toxin-related interleukin 2 fusion protein.
    Grailer AP; Nichols JC; Strom TB; Sollinger HW; Burlingham WJ
    Cell Immunol; 1991 Feb; 132(2):481-93. PubMed ID: 1988163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DAB486IL-2 fusion toxin in refractory rheumatoid arthritis.
    Sewell KL; Parker KC; Woodworth TG; Reuben J; Swartz W; Trentham DE
    Arthritis Rheum; 1993 Sep; 36(9):1223-33. PubMed ID: 8216416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 fusion toxin: targeted therapy for cutaneous T cell lymphoma.
    Foss FM
    Ann N Y Acad Sci; 2001 Sep; 941():166-76. PubMed ID: 11594570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 (IL-2) receptor expression and sensitivity to diphteria fusion toxin DAB389IL-2 in cultured hematopoietic cells.
    Re GG; Waters C; Poisson L; Willingham MC; Sugamura K; Frankel AE
    Cancer Res; 1996 Jun; 56(11):2590-5. PubMed ID: 8653702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivity of human myeloma cell lines and normal bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin 6 fusion protein.
    Chadwick DE; Jean LF; Jamal N; Messner HA; Murphy JR; Minden MD
    Br J Haematol; 1993 Sep; 85(1):25-36. PubMed ID: 8251407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells.
    Williams DP; Snider CE; Strom TB; Murphy JR
    J Biol Chem; 1990 Jul; 265(20):11885-9. PubMed ID: 2195027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.
    Potala S; Verma RS
    J Biotechnol; 2010 Jul; 148(2-3):147-55. PubMed ID: 20580754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia.
    LeMaistre CF; Rosenblum MG; Reuben JM; Parkinson DR; Meneghetti CM; Parker K; Shaw JP; Deisseroth AB; Woodworth T
    Lancet; 1991 May; 337(8750):1124-5. PubMed ID: 1674015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting diphtheria toxin to growth factor receptors.
    Murphy JR; vanderSpek JC
    Semin Cancer Biol; 1995 Oct; 6(5):259-67. PubMed ID: 8562903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 fusion protein (DAB389IL-2) selectively targets activated human peripheral blood and lamina propria lymphocytes.
    Bousvaros A; Stevens AC; Strom TB; Murphy J; Lamont JT
    Dig Dis Sci; 1997 Jul; 42(7):1542-8. PubMed ID: 9246061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
    Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
    Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
    Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
    Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.